MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 113 filers reported holding MERSANA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,517 | -71.8% | 53,162 | -27.0% | 0.00% | – |
| Q2 2023 | $239,633 | +60.0% | 72,837 | +99.8% | 0.00% | – |
| Q1 2023 | $149,810 | -27.4% | 36,450 | +3.6% | 0.00% | – |
| Q4 2022 | $206,208 | -10.0% | 35,189 | +3.8% | 0.00% | – |
| Q3 2022 | $229,000 | +57.9% | 33,887 | +7.4% | 0.00% | – |
| Q2 2022 | $145,000 | +43.6% | 31,546 | +24.7% | 0.00% | – |
| Q1 2022 | $101,000 | -35.3% | 25,295 | +0.7% | 0.00% | – |
| Q4 2021 | $156,000 | -33.9% | 25,114 | 0.0% | 0.00% | – |
| Q3 2021 | $236,000 | +24.2% | 25,114 | +79.3% | 0.00% | – |
| Q2 2021 | $190,000 | -10.4% | 14,006 | +6.9% | 0.00% | – |
| Q1 2021 | $212,000 | -41.4% | 13,097 | -3.7% | 0.00% | – |
| Q4 2020 | $362,000 | +42.0% | 13,605 | -0.7% | 0.00% | – |
| Q3 2020 | $255,000 | -26.5% | 13,702 | -7.5% | 0.00% | – |
| Q2 2020 | $347,000 | +1185.2% | 14,818 | +213.6% | 0.00% | – |
| Q1 2020 | $27,000 | -20.6% | 4,725 | -21.2% | 0.00% | – |
| Q4 2019 | $34,000 | +277.8% | 5,995 | 0.0% | 0.00% | – |
| Q3 2019 | $9,000 | -62.5% | 5,995 | 0.0% | 0.00% | – |
| Q2 2019 | $24,000 | +140.0% | 5,995 | +210.1% | 0.00% | – |
| Q1 2019 | $10,000 | +25.0% | 1,933 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -57.9% | 1,933 | 0.0% | 0.00% | – |
| Q3 2018 | $19,000 | -45.7% | 1,933 | 0.0% | 0.00% | – |
| Q2 2018 | $35,000 | +12.9% | 1,933 | -1.1% | 0.00% | – |
| Q1 2018 | $31,000 | +158.3% | 1,955 | +178.1% | 0.00% | – |
| Q4 2017 | $12,000 | 0.0% | 703 | 0.0% | 0.00% | – |
| Q3 2017 | $12,000 | – | 703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |